openPR Logo
Press release

Up to 30% of women in the GCC and South Asia suffer from infertility resulting from PCOS

03-14-2016 02:55 PM CET | Health & Medicine

Press release from: Informa Life Sciences Exhibitions

Up to 30% of women in the GCC and South Asia suffer from infertility

Dubai, UAE: There is a high incidence of polycystic ovarian syndrome (PCOS) in the Middle East/GCC region mainly due to hereditary and ethnic influences. Approximately up to 20-25% of women in the GCC of Middle Eastern and South Asian ethnicity suffer from PCOS. Experts believe that cases can reach 30% or even higher in the subfertility population in the region. The Obs Gyne Conference aims to tackle the different challenges, treatments and share the latest updates concerning the management of PCOS.

PCOS is the most common endocrine abnormality in women of reproductive age worldwide. It is a genetic disorder with a broad spectrum of clinical and morphological outcomes. It was defined in 1935, and initially called Stein – Leventhal Syndrome, when American gynaecologists Irving F. Stein, Sr., and Michael L. Leventhal associated the presence of ovarian cysts with anovulation. It is an unavoidable disease but can be managed at any age depending on the patient’s needs and expectations at the time.

“PCOS can present in any age especially after weight gain, but can also first present in young adolescent girls. The symptoms associated with this condition vary, but may include some of the following: irregular or absent menstrual periods, hirsutism (increased hair growth), alopecia (female pattern baldness), oily skin & acne, weight related issues, and infertility or difficulty in getting pregnant,” says Dr Salem El Shawarby, Consultant & UK Subspecialist in Reproductive Medicine/ IVF, Director of
Corniche Fertility Centre, Corniche Hospital, Abu Dhabi, UAE.

Dr El Shawarby will discuss the prevention of long-term health hazards in PCOS women at the reproductive health and infertility conference at the Obs-Gyne Exhibition and Congress that will take place March 27-29 at the Dubai International Convention and Exhibition Centre.

Women with PCOS are at greater risk for developing certain complications during pregnancy. In addition, infants born to mothers with PCOS are at higher risk of spending time in the neonatal intensive care unit. Complications of pregnancy associated with PCOS, such as preeclampsia, could be a reason for these risks. Also, conditions common to PCOS like metabolic syndromes such as diabetes and increased androgens may increase the risks affecting infants.

“The best approach to managing PCOS is regular exercise, a healthy balanced food program, and adequate weight control. Lifestyle changes are often initiated as fist line of treatment for improvement of short and long-term outcomes and should precede and/or accompany any pharmacological treatment. Women known to have the condition should not in general delay getting pregnant, and should seek expert fertility advice earlier” highlighted Dr El Shawarby.

Informa Life Sciences Exhibitions, in charge of the healthcare portfolio within Informa's Global Exhibitions division, organises 26 exhibitions yearly covering the Middle East, Africa, Asia, Europe and US market, connecting more than 150,000 healthcare professionals worldwide and offering a range of marketing solutions for companies involved with the healthcare sector. Over 100 congresses take place in parallel with the exhibitions.

Dubai, UAE P.O Box 9248

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Up to 30% of women in the GCC and South Asia suffer from infertility resulting from PCOS here

News-ID: 325848 • Views:

More Releases from Informa Life Sciences Exhibitions

3rd edition of MEDLAB Asia Pacific unveils state of the art laboratory innovations
3rd edition of MEDLAB Asia Pacific unveils state of the art laboratory innovatio …
Singapore, Singapore: The 3rd MEDLAB Asia Pacific Exhibition and Conference, organised by Informa Life Sciences Exhibitions commenced today and will continue until March 24 2016. It is held at the Sands Expo and Convention Centre, Singapore. The conference programme will featured in total nine CME-accredited conference tracks, accredited by the Singapore Medical Council. The exhibition will feature some of the key industry leaders such as, BioMerieux, Bio-Rad, EUROIMMUN, Siemens, Abbott,
Building Healthcare Exhibition delivers vital platform for decision makers in the Middle East industry
Building Healthcare Exhibition delivers vital platform for decision makers in th …
Dubai, UAE: Building Healthcare Exhibition & Conferences, organised by Informa Life Sciences Exhibitions, will take place 30 May - June 1 2016, at the Dubai International Convention and Exhibition Centre. The exhibition will bring together more than 6,000 leading investors, healthcare CEOs, government representatives, IT decision makers, architects, and more, to discuss the future of healthcare and source the most cutting-edge technologies, products and services available to ensure the
Total Laboratory Automation Key Topic at MEDLAB Asia Pacific 2016
Total Laboratory Automation Key Topic at MEDLAB Asia Pacific 2016
Singapore: Laboratories are under immense pressure to improve turnaround times, reduce human error rates, and improve efficiency while reducing costs. Those are the drivers for today’s automation of most of the clinical laboratories. Laboratory automation stands for the use of technology to minimalize or even eliminate manual handling of equipment and processes. In today’s fast moving healthcare industry, automation becomes crucial in laboratories for handling high volumes of samples at

All 4 Releases


More Releases for PCOS

Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728 Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.
06-20-2024 | Health & Medicine
Fact.MR
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness. Get Free Sample Research Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10043 PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms